SKI expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.890000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.055000E-01
Normal-vs-Stage2
9.565200E-01
Normal-vs-Stage3
3.610200E-01
Normal-vs-Stage4
1.052810E-01
Stage1-vs-Stage2
3.250800E-01
Stage1-vs-Stage3
6.615800E-01
Stage1-vs-Stage4
6.803200E-03
Stage2-vs-Stage3
2.183400E-01
Stage2-vs-Stage4
3.290100E-02
Stage3-vs-Stage4
3.447700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.558000E-01
Normal-vs-AfricanAmerican
8.481200E-01
Normal-vs-Asian
8.623200E-01
Caucasian-vs-AfricanAmerican
9.945600E-01
Caucasian-vs-Asian
5.778800E-01
AfricanAmerican-vs-Asian
6.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.923800E-01
Normal-vs-Female
9.733800E-01
Male-vs-Female
2.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.636400E-01
Normal-vs-Age(41-60Yrs)
6.716600E-01
Normal-vs-Age(61-80Yrs)
7.220800E-01
Normal-vs-Age(81-100Yrs)
4.572000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.706200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.268000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.470200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.864000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.606100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.266800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.302800E-01
Normal-vs-Daily Drinker
6.394000E-01
Normal-vs-Weekly Drinker
6.607400E-01
Normal-vs-Occasional Drinker
8.627000E-01
Normal-vs-Social Drinker
9.865400E-01
Non Drinker-vs-Daily Drinker
9.882600E-01
Non Drinker-vs-Weekly Drinker
1.542590E-01
Non Drinker-vs-Occasional Drinker
6.196200E-01
Non Drinker-vs-Social Drinker
3.997400E-01
Daily Drinker-vs-Weekly Drinker
1.075760E-01
Daily Drinker-vs-Occasional Drinker
5.457400E-01
Daily Drinker-vs-Social Drinker
3.705000E-01
Weekly Drinker-vs-Occasional Drinker
2.604000E-01
Weekly Drinker-vs-Social Drinker
3.765000E-01
Occasional Drinker-vs-Social Drinker
7.648200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.582600E-01
Normal-vs-Grade 2
8.398600E-01
Normal-vs-Grade 3
8.704600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.843970E-03
Grade 1-vs-Grade 3
1.527730E-02
Grade 1-vs-Grade 4
9.582600E-01
Grade 2-vs-Grade 3
5.459600E-01
Grade 2-vs-Grade 4
8.398600E-01
Grade 3-vs-Grade 4
8.704600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.264800E-01
Normal-vs-NonDiabetic
8.473000E-01
Diabetic-vs-NonDiabetic
8.031800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.861200E-01
Normal-vs-NoPancreatitis
8.842000E-01
Pancreatitis-vs-NoPancreatitis
5.722800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.809600E-01
Normal-vs-N1
9.720600E-01
N0-vs-N1
1.845390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.195000E-01
Normal-vs-TP53-NonMutant
4.417000E-01
TP53-Mutant-vs-TP53-NonMutant
2.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
